Page last updated: 2024-11-04

vorinostat and Malaria, Falciparum

vorinostat has been researched along with Malaria, Falciparum in 3 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Malaria, Falciparum: Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Dow, GS1
Chen, Y1
Andrews, KT2
Caridha, D1
Gerena, L1
Gettayacamin, M1
Johnson, J1
Li, Q1
Melendez, V1
Obaldia, N1
Tran, TN1
Kozikowski, AP1
Diedrich, D1
Stenzel, K1
Hesping, E1
Antonova-Koch, Y1
Gebru, T1
Duffy, S1
Fisher, G1
Schöler, A1
Meister, S1
Kurz, T1
Avery, VM1
Winzeler, EA1
Held, J1
Hansen, FK1
Nardella, F1
Halby, L1
Dobrescu, I1
Viluma, J1
Bon, C1
Claes, A1
Cadet-Daniel, V1
Tafit, A1
Roesch, C1
Hammam, E1
Erdmann, D1
Mairet-Khedim, M1
Peronet, R1
Mecheri, S1
Witkowski, B1
Scherf, A1
Arimondo, PB1

Other Studies

3 other studies available for vorinostat and Malaria, Falciparum

ArticleYear
Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Animals; Antimalarials; Aotidae; Drug Resistance; Enzyme Inhibitors; Histone Deacetylase Inhibitors;

2008
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
    European journal of medicinal chemistry, 2018, Oct-05, Volume: 158

    Topics: Acetylation; Antimalarials; Hep G2 Cells; Histone Deacetylase Inhibitors; Histones; Humans; Malaria,

2018
Procainamide-SAHA Fused Inhibitors of hHDAC6 Tackle Multidrug-Resistant Malaria Parasites.
    Journal of medicinal chemistry, 2021, 07-22, Volume: 64, Issue:14

    Topics: Antimalarials; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Histone Deacetylase 6; H

2021